In 2022, the United States experienced a severe shortage of infant formula as a result of the 2021–2022 global supply chain crisis compounded by a large scale product recall after two babies allegedly died after consuming Abbott infant formula, import restrictions, and market concentration. Unlike other food products, infant formula often does not have an available and acceptable substitute as a source of nutrition for those who rely on it. In addition to infants, the formula recalls affected non-infant medical patients who require nasogastric feeding or have certain other conditions.